Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for Levothyroxine 100micrograms/5ml Oral Solution by Wockhardt UK Ltd.
The company is recalling specific batches of the medicine from pharmacies and wholesalers as a precautionary measure due to notification of the impurity liothyronine exceeding the specification limit.
Affected Batches:
| Batch Number | Expiry Date | Pack Size | First Distributed |
| I53481 | 31/03/2020 | 1 x 100ml | 15/04/2019 |
| I54522 | 31/05/2021 | 1 x 100ml | 03/10/2019 |
Liothyronine is a degradant of Levothyroxine and can be used to treat the same conditions but with a faster onset and considered to be more potent than levothyroxine. This potency difference will result in different pharmacodynamic effects for patients, the drug alert notes.
Pharmacists are advised to stop supplying the above products immediately. They should quarantine all remaining stock and return it to their original supplier using supplier’s approved process.
Company contacts for further information:
For medical Information enquiries, please contact Medical Information on 01978 661261 or email [email protected]. For enquiries relating to stock returns please contact Wockhardt UK Ltd Customer Services on 01978 661261 or email [email protected].
Levothyroxine 100micrograms/5ml Oral Solution – PL 29831/0495 – PIP code: 123-0051
